EyePoint Pharmaceuticals Inc.
EYPT | NASDAQ
$4.02
+$0.17 (+4.42%)
At close: Sep 21, 2026, 4:00 PM ET
$4.05
+$0.03 (+0.75%)
Pre-market:
Sep 22, 2026, 8:58 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 31.37M | 43.27M | 46.02M | 41.4M | 36.94M | 34.44M |
Cost of Revenue | 2.07M | 3.71M | 4.63M | 8.33M | 8.18M | 5.82M |
Gross Profit | 29.31M | 39.56M | 41.39M | 33.08M | 28.76M | 28.61M |
Operating Income | -243.43M | -145.85M | -75.07M | -99.64M | -55.28M | -37.29M |
Interest Income | 11.75M | 15.09M | 6.95M | 2.13M | 292K | 58K |
Pretax Income | -231.68M | -130.78M | -70.71M | -102.25M | -58.42M | -45.39M |
Net Income | -231.96M | -130.87M | -70.8M | -102.25M | -58.42M | -45.39M |
Selling & General & Admin | 51.7M | 52.49M | 51.79M | 60.32M | 53.08M | 46.02M |
Research & Development | 221.04M | 132.93M | 64.66M | 49.64M | 28.5M | 17.42M |
Other Expenses | n/a | n/a | n/a | 22.75M | 2.46M | 2.46M |
Operating Expenses | 272.74M | 185.42M | 116.45M | 132.72M | 84.04M | 65.9M |
Interest Expense | -33K | 14K | 1.25M | 3.19M | 5.5M | 7.26M |
Selling & Marketing Expenses | 90K | 131K | 11.69M | 25.51M | 27.5M | 25.29M |
Cost & Expenses | 274.81M | 189.13M | 121.09M | 141.04M | 92.22M | 71.73M |
Income Tax Expense | 279K | 90K | 83K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 73.25M | 56.3M | 38.9M | 37.32M | 28.76M | 12.84M |
Shares Outstanding (Diluted) | 73.25M | 56.3M | 38.9M | 37.32M | 28.76M | 12.84M |
EPS (Basic) | -3.17 | -2.32 | -1.82 | -2.74 | -2.03 | -3.54 |
EPS (Diluted) | -3.17 | -2.32 | -1.82 | -2.74 | -2.03 | -3.54 |
EBITDA | -229.34M | -129.23M | -69M | -96.62M | -50.15M | -35.49M |
EBIT | -231.65M | -130.77M | -69.47M | -99.07M | -52.92M | -38.14M |
Depreciation & Amortization | 2.31M | 1.54M | 464K | 2.45M | 2.77M | 2.65M |
Add to Watchlist
Select watchlists to add or remove EYPT